Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: a case report
- PMID: 23162598
- PMCID: PMC3496854
- DOI: 10.5812/hepatmon.5871
Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: a case report
Abstract
Coincidental occurrence of hepatocellular carcinoma (HCC) and cholangiocarcinoma, known as "collision tumors", within a cirrhotic liver is rare. Herein, we report a case of liver transplantation (LT) in a patient with such collision tumors. Our patient was a 56-year-old woman with hepatitis C virus-related cirrhosis and 2 focal hepatic lesions, measuring 1.5 and 3 cm, in the liver segments 8 and 5, respectively. The lesion on segment 8 showed the typical radiological characteristics of HCC; however, the lesion in segment 5 showed an atypical vascular pattern and was closely associated with the inferior vena cava. Serum alpha-fetoprotein level was normal and serum carbohydrate antigen 19-9 (CA19-9) level was slightly elevated (63 U/mL); the extrahepatic spread of HCC was ruled out. The patient underwent an uneventful deceased-donor LT. Histopathological examination of the explant confirmed that the lesion on segment 8 was an HCC, but surprisingly, the lesion on segment 5 was found to be a cholangiocarcinoma. Six months after LT, the serum CA19-9 level was markedly elevated (255 U/mL), and the patient began experiencing abdominal pain. Magnetic resonance imaging showed enlarged hilar and paraaortic lymph nodes that were suggestive of metastases; histopathological analysis using ultrasound (US)-guided biopsy confirmed recurrent cholangiocarcinoma. Unfortunately, the patient died because of tumor recurrence 9 months after LT.Collision tumor resulting from the co-existence HCC and cholangiocarcinoma in a cirrhotic liver is rare and has a negative impact on the outcome of LT. Atypical vascular pattern and elevated serum CA19-9 levels are suggestive of such tumors; patients with these findings should undergo a targeted biopsy to rule out the coincidental occurrence of HCC and cholangiocarcinoma.
Keywords: Biopsy; CA19-9 Antigen; Hepatic Lesion; Recurrence.
Figures



Similar articles
-
Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.Surg Today. 2017 Aug;47(8):908-917. doi: 10.1007/s00595-017-1472-3. Epub 2017 Jan 25. Surg Today. 2017. PMID: 28124125 Review.
-
Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.Liver Transpl. 2018 Oct;24(10):1384-1397. doi: 10.1002/lt.25058. Liver Transpl. 2018. PMID: 29573187
-
Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.World J Gastroenterol. 2020 Dec 14;26(46):7325-7337. doi: 10.3748/wjg.v26.i46.7325. World J Gastroenterol. 2020. PMID: 33362387 Free PMC article.
-
Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.BMC Cancer. 2016 Feb 25;16:158. doi: 10.1186/s12885-016-2156-x. BMC Cancer. 2016. PMID: 26917546 Free PMC article.
-
Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature.World J Gastroenterol. 2016 Nov 7;22(41):9229-9234. doi: 10.3748/wjg.v22.i41.9229. World J Gastroenterol. 2016. PMID: 27895410 Free PMC article. Review.
Cited by
-
Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression.Hepat Mon. 2014 Dec 15;14(12):e23552. doi: 10.5812/hepatmon.23552. eCollection 2014 Dec. Hepat Mon. 2014. PMID: 25685165 Free PMC article.
-
Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.Surg Today. 2017 Aug;47(8):908-917. doi: 10.1007/s00595-017-1472-3. Epub 2017 Jan 25. Surg Today. 2017. PMID: 28124125 Review.
-
Different faces of hepatocellular carcinoma as a health threat in 21st century.Hepat Mon. 2013 Feb 4;13(2):e9308. doi: 10.5812/hepatmon.9308. Print 2013 Feb. Hepat Mon. 2013. PMID: 23613688 Free PMC article. No abstract available.
References
-
- Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol. 2010;105(3):599–609. doi: 10.1038/ajg.2009.654. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources